R&D Structure Using Collaborative and Contract Research
First written in FY2023. 6 of 9 entries say "Advanced", first in FY2024-Q1. Latest entry: FY2027-H1.
25 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「The Company also continued examining expanded indications for TMS-008 and began collaborative research with Kyushu University and Tohoku University.」
Under its external collaboration model, the Company began new collaborative research with Kyushu University and Tohoku University on expanded indications for TMS-008. - FY2025RestatedAnnual report
「To advance R&D, the Company actively uses external resources, including collaborative and contract research with external organizations, from basic exploratory research through nonclinical and clinical research, thereby establishing and operating an efficient structure.」
The Company continues to use collaborative and contract research and other external resources from the exploratory stage through clinical development. - FY2024-Q3AdvancedAnnual report
「The Company also entered into a three-party joint research agreement including Kanazawa University. Through the collaborative research chair established at Tokyo University of Agriculture and Technology in April 2023, it is using university collaboration to develop new pipeline candidates.」
The Company deepened collaboration with universities and research institutions by entering into a three-party joint research agreement including Kanazawa University. - FY2024-Q2RestatedAnnual report
「To enhance its R&D capabilities, the Company established a collaborative research chair at Tokyo University of Agriculture and Technology in April 2023.」
The Company reiterated its efforts to strengthen R&D capabilities through the collaborative research chair established in April 2023. - FY2024-Q1AdvancedAnnual report
「To enhance its R&D capabilities, the Company established a collaborative research chair at Tokyo University of Agriculture and Technology in April 2023.」
The Company established a collaborative research chair at Tokyo University of Agriculture and Technology in April 2023 to strengthen R&D capabilities. - FY2023First statedAnnual report
「To advance R&D, the Company actively uses external resources, including collaborative and contract research with external organizations, from basic exploratory research through nonclinical and clinical research, thereby establishing and operating an efficient structure.」
The Company actively uses collaborative and contract research with external organizations from exploratory research through clinical trials to maintain an efficient development structure.